[皮肤病学中生物技术药物的变种:现状和未来]
Johannes Wohlrab1,2, Adina Eichner3,4
1Universitätsklinik und Poliklinik für Dermatologie und Venerologie, Martin-Luther-Universität Halle-Wittenberg, Ernst-Grube-Str. 40, 06097, Halle (Saale), Deutschland. johannes.wohlrab@medizin.uni-halle.de.
Dermatologie (Heidelberg, Germany)
|August 22, 2024
概括
生物制药,复杂的生物技术药物,为癌症和炎症性皮肤疾病提供了创新的治疗方法. 分子医学的不断进步正在扩大其治疗和诊断潜力.
科学领域:
- 生物技术和制药科学 生物技术和制药科学
- 分子医学是分子医学.
- 皮肤病学 皮肤病学
背景情况:
- 生物制药,包括单克隆抗体,蛋白质和融合蛋白质,具有复杂的结构和独特的特性.
- 诸如抗体碎片,纳米体,和抗体-药物联合体等变异在临床环境中越来越多地使用.
- 生物制药正在开发用于瘤和慢性炎症疾病,在皮肤病学中越来越重要.
研究的目的:
- 要突出生物制药产品的不断变化的格局.
- 讨论用于局部应用的生物制药的开发.
- 强调先进分子医学在创造新的治疗和诊断选择方面的潜力.
主要方法:
- 审查当前生物制药变异及其临床应用.
- 对局部生物制药输送策略的分析.
- 探索分子医学在目标识别和分子设计方面的进步.
主要成果:
- 抗体碎片,纳米体,和抗体-药物联合体代表了重要的生物技术进步.
- 生物制药在治疗瘤和炎症疾病,特别是在皮肤病学方面,表现出显著的优势.
- 精细的方法使得制造药理学上有利的生物技术分子成为可能.
结论:
- 生物制药领域正在迅速发展,提供创新的治疗和诊断解决方案.
- 在分子医学领域的持续研究将确定新的目标,并提高生物制药剂的设计.
- 局部生物制药的发展为皮肤病治疗提供了有前途的途径.
相关概念视频
Prodrugs
2.6K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
2.6K
Drug Biotransformation: Overview
2.4K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
2.4K
Bioequivalence: Overview
949
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
949
Biopharmaceutics and Pharmacokinetics: Overview
1.9K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
1.9K
Drug Administration and Therapy Phases: Overview
418
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
418
Drug Delivery: Overview
279
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
279


